Results 201 to 210 of about 182,098 (265)

Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. [PDF]

World J Gastroenterol
Tomassoni DR, Schildkraut T, Ramachandran V, Cooke JC, Sawhney R.   +4 more
europepmc   +1 more source

Optimal guiding methods for transjugular intrahepatic portosystemic shunt creation: Characteristics of intravascular ultrasound <i>vs</i> other techniques. [PDF]

World J Hepatol
Miao L, Ren JL, Zhao H, Li X.
europepmc   +1 more source

Prediction of Congenital Portosystemic Shunt in Neonatal Hypergalactosemia Using Gal-1-P/Gal Ratio, Bile Acid, and Ammonia. [PDF]

Int J Neonatal Screen
Suzuki-Ajihara S, Musha I, Arao M, Mori K, Fujibayashi S, Ryo I, Kono T, Tajima A, Mochizuki H, Imai-Okazaki A, Araki R, Numakura C, Ohtake A.   +12 more
europepmc   +1 more source

Prominent Eustachian Valve Mimicking a Transjugular Intrahepatic Portosystemic Shunt-Associated Thrombosis. [PDF]

ACG Case Rep J
Malik G, Herget E, Nguyen HH, Swain MG.
europepmc   +1 more source

An Anomalous Connection of the Left Hepatic Vein with the Coronary Sinus in a Selkirk Rex Cat with a Portosystemic Shunt. [PDF]

Vet Radiol Ultrasound
Park J, Noh D, Lee SK, Lee K.
europepmc   +1 more source

Coil Embolization of a Portosystemic Shunt Presenting as a Varicocele. [PDF]

ACG Case Rep J
Galate V, Kozlowski I, Vogt C, Ash R, Alli A, Rohr A.   +5 more
europepmc   +1 more source

Which patients benefit the most? An update on transjugular intrahepatic portosystemic shunt. [PDF]

World J Hepatol
de Mattos AA, de Mattos AZ, Manica M, Tovo CV.   +3 more
europepmc   +1 more source

Electroencephalographic Features of Presumed Hepatic Encephalopathy in a Pediatric Dog with a Portosystemic Shunt-A Case Report. [PDF]

Life (Basel)
Ștefănescu RA, Boghian V, Solcan G, Codreanu MD, Musteata M.   +4 more
europepmc   +1 more source

Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on "Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis". [PDF]

Clin Mol Hepatol
Semmler G, Balcar L, Mandorfer M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.

Radiology, 2022
Background Sarcopenia is frequently found in patients with cirrhosis and is associated with liver dysfunction, cirrhosis-related complications, and poorer quality of life.
Jiacheng Liu, Jinqiang Ma, Chongtu Yang, Manman Chen, Qin Shi, Chen Zhou, Songjiang Huang, Yang Chen, Yingliang Wang, Tongqiang Li, B. Xiong   +10 more
semanticscholar   +1 more source